Lorella Melillo

7.0k total citations
56 papers, 1.5k citations indexed

About

Lorella Melillo is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lorella Melillo has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 18 papers in Oncology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lorella Melillo's work include Acute Myeloid Leukemia Research (22 papers), Acute Lymphoblastic Leukemia research (13 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Lorella Melillo is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Acute Lymphoblastic Leukemia research (13 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Lorella Melillo collaborates with scholars based in Italy, United States and Netherlands. Lorella Melillo's co-authors include Livio Pagano, Bruno Martino, M Carotenuto, Nicola Cascavilla, Pellegrino Musto, Rosa Fanci, M Buelli, Domenico D’Antonio, Giorgina Specchia and Corrado Girmenia and has published in prestigious journals such as Blood, NeuroImage and Clinical Infectious Diseases.

In The Last Decade

Lorella Melillo

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorella Melillo Italy 20 559 528 434 367 280 56 1.5k
Jolán E. Walter United States 29 568 1.0× 309 0.6× 240 0.6× 162 0.4× 266 0.9× 121 2.4k
Andrew J. Cant United Kingdom 32 566 1.0× 682 1.3× 771 1.8× 438 1.2× 502 1.8× 88 3.5k
David Dennison Oman 24 174 0.3× 197 0.4× 526 1.2× 127 0.3× 401 1.4× 89 1.8k
Iria Neri Italy 27 389 0.7× 461 0.9× 88 0.2× 223 0.6× 294 1.1× 265 2.6k
Kathy Frees United States 11 139 0.2× 523 1.0× 173 0.4× 69 0.2× 296 1.1× 12 2.2k
Cecilia Simonelli Italy 24 372 0.7× 517 1.0× 69 0.2× 770 2.1× 229 0.8× 78 3.2k
Albert C. Yan United States 29 248 0.4× 363 0.7× 60 0.1× 152 0.4× 331 1.2× 121 2.4k
Mohammad Naderi Iran 20 487 0.9× 1.7k 3.1× 49 0.1× 128 0.3× 280 1.0× 78 2.5k
Hermann M. Wolf Austria 23 271 0.5× 323 0.6× 235 0.5× 203 0.6× 214 0.8× 82 1.9k
G. R. F. Krueger Germany 23 329 0.6× 770 1.5× 103 0.2× 671 1.8× 145 0.5× 129 1.8k

Countries citing papers authored by Lorella Melillo

Since Specialization
Citations

This map shows the geographic impact of Lorella Melillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorella Melillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorella Melillo more than expected).

Fields of papers citing papers by Lorella Melillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorella Melillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorella Melillo. The network helps show where Lorella Melillo may publish in the future.

Co-authorship network of co-authors of Lorella Melillo

This figure shows the co-authorship network connecting the top 25 collaborators of Lorella Melillo. A scholar is included among the top collaborators of Lorella Melillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorella Melillo. Lorella Melillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Oswald, Laura B., Adriano Venditti, David Cella, et al.. (2021). Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors. BMJ Supportive & Palliative Care. 13(e2). e344–e351. 3 indexed citations
3.
Delia, Mario, Paola Carluccio, Caterina Buquicchio, et al.. (2015). Azacitidine in the treatment of older patients affected by acute myeloid leukemia: A report by the Rete Ematologica Pugliese (REP). Leukemia Research. 39(11). 1166–1171. 4 indexed citations
4.
Rossi, Giovanni, Maria Marta Minervini, Lorella Melillo, et al.. (2014). Predictive role of minimal residual disease and log clearance in acute myeloid leukemia: a comparison between multiparameter flow cytometry and Wilm’s tumor 1 levels. Annals of Hematology. 93(7). 1149–57. 26 indexed citations
5.
Latagliata, Roberto, Massimo Breccia, Paola Fazi, et al.. (2011). GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long‐term results and prognostic factors. British Journal of Haematology. 154(5). 564–568. 14 indexed citations
6.
Rossi, Giovanni, Maria Marta Minervini, Angelo Michele Carella, et al.. (2011). Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets. Leukemia Research. 36(4). 401–406. 31 indexed citations
7.
Ottone, Tiziana, Laura Cicconi, Syed K. Hasan, et al.. (2011). Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia. Leukemia Research. 36(4). 474–478. 7 indexed citations
8.
Melillo, Lorella, Elvira Grandone, Donatella Colaizzo, et al.. (2007). Symptomatic Venous Thromboembolism and Thrombophilic Status in Adult Acute Leukemia: A Single-Center Experience of 114 Patients at Diagnosis. Acta Haematologica. 117(4). 215–220. 28 indexed citations
9.
Melillo, Lorella, Nicola Cascavilla, Enrica Lerma, Maria Teresa Corsetti, & Angelo Michele Carella. (2005). The Significance of Minimal Residual Disease in Stem Cell Grafts and the Role of Purging: Is It Better to Purge in vivo or in vitro?. Acta Haematologica. 114(4). 206–213. 6 indexed citations
10.
Musto, Pellegrino, Antonietta Falcone, Grazia Sanpaolo, et al.. (2003). Pamidronate Reduces Skeletal Events but does not Improve Progression-free Survival in Early-stage Untreated Myeloma: Results of a Randomized Trial. Leukemia & lymphoma. 44(9). 1545–1548. 27 indexed citations
11.
Prvulovic, David, Daniela Hubl, Alexander T. Sack, et al.. (2002). Functional Imaging of Visuospatial Processing in Alzheimer's Disease. NeuroImage. 17(3). 1403–1414. 155 indexed citations
12.
Pagano, Livio, Alessandro Pulsoni, Luca Mele, et al.. (2001). Acute myeloid leukemia in patients previously diagnosed with breast cancer: Experience of the GIMEMA group. Annals of Oncology. 12(2). 203–208. 14 indexed citations
13.
Cascavilla, Nicola, Lorella Melillo, Giovanni D’Arena, et al.. (2000). Minimally Differentiated Acute Myeloid Leukemia (AML M0): Clinico-Biological Findings of 29 Cases. Leukemia & lymphoma. 37(1-2). 105–113. 17 indexed citations
14.
Pagano, Livio, Andrea Antinori, Adriana Ammassari, et al.. (1999). Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes. European Journal Of Haematology. 63(2). 77–85. 75 indexed citations
15.
Ferrara, Felicetto, Lorella Melillo, Marco Montillo, et al.. (1999). Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation. Annals of Hematology. 78(8). 380–384. 34 indexed citations
16.
Cascavilla, Nicola, Pellegrino Musto, Giovanni D’Arena, et al.. (1996). Are “Early” and “Late” T-Acute Lymphoblastic Leukemias Different Diseases? A Single Center Study of 34 Patients. Leukemia & lymphoma. 21(5-6). 437–442. 6 indexed citations
17.
18.
Melillo, Lorella, et al.. (1993). Exacerbation of porokeratosis: A sign of immunodepression. Journal of the American Academy of Dermatology. 29(6). 1035–1036. 11 indexed citations
19.
20.
Cascavilla, Nicola, Saverio Ladogana, Antonio La Sala, et al.. (1988). Acute myeloid leukemia: correlation between FAB classification criteria and surface antigenic markers.. PubMed. 73(1). 37–42. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jolán E. Walter Breakdown of academic impact, for papers by Andrew J. Cant Breakdown of academic impact, for papers by David Dennison Breakdown of academic impact, for papers by Iria Neri Breakdown of academic impact, for papers by Kathy Frees Breakdown of academic impact, for papers by Cecilia Simonelli Breakdown of academic impact, for papers by Albert C. Yan Breakdown of academic impact, for papers by Mohammad Naderi Breakdown of academic impact, for papers by Hermann M. Wolf Breakdown of academic impact, for papers by G. R. F. Krueger
Rankless by CCL
2026